Lieping Chen, MD, PhD
United Technologies Corporation Professor in Cancer Research and Professor of Immunobiology, of Dermatology and of Medicine (Medical Oncology)
Biography
Research & Publications
News
Locations
Appointments
Biography
Dr. Lieping Chen is an immunologist interested in basic T cell biology, cancer immunology and translational research to develop innovative medicine for treating human diseases including cancer. Prior to joining Yale, he was faculty members at Johns Hopkins University School of Medicine and Mayo Clinic, and was a research scientist in Bristol-Myers Squibb/Oncogen in Seattle, Washington.
Dr. Chen has published over 370 peer-reviewed research articles. His work in discovery of the PD-1/PD-L1 pathway for cancer immunotherapy was cited as the #1 breakthrough of the years by Science magazine 2013. He is a member of the National Academy of Sciences and a fellow of the American Association for Cancer Research.
Education & Training
- PhDDrexel University, Pathology and Laboratory Medicine (1989)
- MSBeijing Union Medical College, Immunology (1986)
- MDFujian Medical College (1982)
Honors & Recognition
| Award | Awarding Organization | Date |
|---|---|---|
| Fellow | Society for Immunotherapy of Cancer | 2021 |
| Richard V. Smalley MD Memorial Award | Society for Immunotherapy of Cancer | 2020 |
| Academician | Academia Sinica | 2018 |
| Warren Alpert Foundation Prize | Warren Alpert Foundation | 2017 |
| AAI-Steinman Award | American Association of Immunologists | 2016 |
| William B. Coley Award | Cancer Research Institute | 2014 |
Departments & Organizations
- Cancer Immunology
- Chen Lab
- Immunobiology
- Immunology
- Internal Medicine
- K12 Calabresi Immuno-Oncology Training Program (IOTP)
- Medical Oncology
- Office of Cooperative Research
- Rheumatic Diseases Research Core
- Rheumatology, Allergy, & Immunology
- SPORE in Lung Cancer
- Yale Cancer Center
- Yale Combined Program in the Biological and Biomedical Sciences (BBS)